Aurobindo Pharma Q1 profit up 10 pc at Rs 571 cr

With the product pipeline continuing to advance, and execution of growth drivers proceeding as planned, the company is confident that its fundamental strengths position it to create an upward trajectory, Vice-Chairman and Managing Director K Nithyananda Reddy said.

Why Mahantesh Sabarad is bullish on ITC

Some of the IPOs, the hospital IPO Yatharth that you talked about are ones which really bring in value to the table for many of the investors. Even SBFC is kind of a good IPO in a sector more than the company itself, it is a sector which is taking prominence particularly where we are coming out of a COVID situation where the credit growth is expanding by leaps and bounds, according to Mahantesh Sabarad, Market Expert

ONGC Q1 Results: Profit drops 34% YoY to Rs 10,015 crore on lower prices

Revenue for the April-June quarter fell 20% year-on-year to Rs 33,814 crore. The average oil price realized from nomination fields was 29.5% down from a year earlier to $ 76.49 per barrel during the quarter. In rupee terms, the realization was 25% lower at Rs 6,288 per barrel. Oil price realization from joint venture fields fell 31% to Rs 5,808 per barrel